Relay Therapeutics, Inc. (NASDAQ:RLAY) executive Peter Rahmer, the company's Chief Corporate Development Officer, recently sold shares in a transaction connected to the vesting of restricted stock ...
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead ...
Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), has recently sold a significant amount of company stock, according to the latest SEC filings. The ...
Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company ...
Mozart Therapeutics, the leading developer of CD8 Treg network modulators, today announce the release of new pre-clinical data for their second program, a KIR x ICOS bispecific antibody targeting CD8 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results